The PI3K/Akt/mTOR pathway is a central driver of metabolic reprogramming in NSCLC, integrating extracellular signals to promote glucose uptake, glycolytic enzyme expression, and anabolic activity [56]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.